Updates

Date: 13th October, 2026 To, To, The Manager (Listing) Listing Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No. C/1, G Block, Dalal Street, Fort, Bandra-Kurla Complex, Mumbai - 400001 Bandra (E), Mumbai - 400051 BSE Scrip Code: 506260 NSE Symbol: ANUHPHR; Series: EQ Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI LODR’) Dear Sir/Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we wish to inform you that the Board of Directors of Anuh Pharma Limited (the Company) at its meeting held today, Tuesday, 13th October, 2026, has approved the following: 1. Investment in manufacturing assets for expansion of the Company’s production capacity. 2. The proposal to avail a loan of up to ₹ 75 crs (Rupees Seventy Five Crores) for the purchase of manufacturing assets to expand the Company's production capacity, subject to finalisation of the terms and conditions and receipt of applicable approvals, wherever required. The requisite details and annexures, to the extent applicable under the SEBI (LODR) Regulations, 2015, shall be disclosed, as applicable, based on the actual details of the transaction. The Meeting of the Board of Directors commenced at 03:30 p.m. and concluded at 04:35 p.m. This disclosure is also being uploaded on the website of the Company at www.anuhpharma.com You are requested to take note of the above. Thanking you, Yours faithfully, FOR ANUH PHARMA LIMITED MANAN VADHAN COMPANY SECRETARY & COMPLIANCE OFFICER